|
|
| ECZ4068 | @Pharmaceutical care of oncological diseases | 2+0+0 | ECTS:4 | | Year / Semester | Spring Semester | | Level of Course | Second Cycle | | Status | Elective | | Department | DEPARTMENT of PHARMACEUTICS | | Prerequisites and co-requisites | None | | Mode of Delivery | | | Contact Hours | 14 weeks - 2 hours of lectures per week | | Lecturer | Dr. Öğr. Üyesi Mefküre DURMUŞ | | Co-Lecturer | | | Language of instruction | Turkish | | Professional practise ( internship ) | None | | | | The aim of the course: | | To have information about the duties and responsibilities of pharmacists towards patients and, their relatives, physicians and other health care professionals regarding drug treatments, lifestyles, drug administration and drug compliance of patients with oncological diseases. |
| Learning Outcomes | CTPO | TOA | | Upon successful completion of the course, the students will be able to : | | | | LO - 1 : | Gain information about supportive treatment of oncological patients | 9,10 | 1,3,5, | | LO - 2 : | Gain knowledge about drug treatment of oncological diseases | 8,9 | 1,3,5, | | LO - 3 : |
Learn to benefit the pharmaceutical care of patients as a member of the oncology multidisciplinary team | 8,9 | 1,3,5, | | CTPO : Contribution to programme outcomes, TOA :Type of assessment (1: written exam, 2: Oral exam, 3: Homework assignment, 4: Laboratory exercise/exam, 5: Seminar / presentation, 6: Term paper), LO : Learning Outcome | | |
| The topics that pharmacists need to know and practice regarding drug treatments, lifestyles, drug administration and drug compliance of patients with oncological diseases will be explained. |
| |
| Course Syllabus | | Week | Subject | Related Notes / Files | | Week 1 | Adjuvant, neoadjuvant and curative treatment definitions and antineoplastic drug groups | | | Week 2 | Antineoplastic drugs administered by injection and management of their side effects | | | Week 3 | Oral antineoplastic drugs and management of their side effects | | | Week 4 | Antiemetic drugs used in chemotherapy regimens | | | Week 5 | Pain management in oncological patients | | | Week 6 | Other prophylactic drug treatments used in chemotherapy regimens | | | Week 7 | Neutropenic fever and its management | | | Week 8 | Immunotherapy-related side effects and management | | | Week 9 | Midterm week | | | Week 10 | Chemotherapy-related infections and antibiotic prophylaxis | | | Week 11 | Pharmaceutical care in breast cancer | | | Week 12 | Pharmaceutical care in colorectal cancer | | | Week 13 | Pharmaceutical care in lung cancer | | | Week 14 | Pharmaceutical care in lymphomas | | | Week 15 | Presentations and discussion | | | Week 16 | End of term exam week | | | |
| 1 | Whittlesea, C. 2011; Clinical Pharmacy and Therapeutics, 5th edition
| | | 2 | Çelik, T. 2019; Farmakoterapi El Kitabı, Onuncu Baskı, Güneş tıp kitabevleri, Ankara. | | | |
| 1 | Kayaalp, O. 2013; Akılcıl tedavi yönünden tıbbi farmakoloji, Ankara
| | | |
| Method of Assessment | | Type of assessment | Week No | Date | Duration (hours) | Weight (%) | | Mid-term exam | 9 | Nisan 2024 | 1 | 50 | | Homework/Assignment/Term-paper | 16 | 03-14 Haziran 2024 | 1 | 50 | | |
| Student Work Load and its Distribution | | Type of work | Duration (hours pw) | No of weeks / Number of activity | Hours in total per term | | Yüz yüze eğitim | 2 | 14 | 28 | | Ödev | 3 | 6 | 18 | | Kısa sınav | 1 | 1 | 1 | | Total work load | | | 47 |
|